Le Lézard
Classified in: Science and technology

Nucleus Research recognizes Kinaxis as leader in its Control Tower Value Matrix


Kinaxis RapidResponse named a leader among 13 control tower vendors

OTTAWA, Feb. 22, 2018 /CNW/ - Kinaxis Inc. (TSX:KXS), provider of RapidResponse®, a leading cloud-based supply chain management solution based on concurrent planning, has been named a leader by Nucleus Research in its recently published Control Tower Matrix.

Kinaxis' automation and collaboration were two key capabilities cited by Nucleus Research in its ranking of technology solutions in its recently published Control Tower Value Matrix. The research firm named Kinaxis® a leader for its concurrent planning capabilities, which help customers gain better visibility and control of their operations by connecting data, processes and people into a single environment.

The report explores the evolution of supply chain control towers from tools that deliver visibility, to ones that foster collaboration and enable automation. As an early innovator of both attributes, Kinaxis enables enterprises to realize complete supply chain visibility and the ability to concurrently manage planning activities. The report recognizes Kinaxis' ability to connect data, people and processes, stating "RapidResponse gives users the ability to address supply chain issues based on customer-configured key performance indicators. Collaboration capabilities are bolstered by contextual data and information, giving users an archived record of what decision was made and how it was agreed upon."

The Control Tower Value Matrix provides an in-depth review of the top 13 control tower vendors, revealing why Kinaxis RapidResponse® was ranked as a leader.

"The Ottawa, Canada-based vendor's solution integrates data from multiple systems to provide a consolidated view of the entire supply chain, allowing real-time modeling and collaboration with trading partners and logistics providers to plan for expected performance, monitor progress and respond to issues," according to the report, the full content of which is available for download via Kinaxis.com.

Forward-Looking Statements
Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to Kinaxis' growth opportunities and the potential benefits of, and demand for, Kinaxis' products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry. Readers are cautioned not to place undue reliance on such statements. Kinaxis' actual results, performance, achievements and developments may differ materially from the results, performance, achievements or developments expressed or implied by such statements. Risk factors that may cause the actual results, performance, achievements or developments of Kinaxis to differ materially from the results, performance, achievements or developments expressed or implied by such statements can be found in the public documents filed by Kinaxis with Canadian securities regulatory authorities. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

For more Kinaxis news, follow us on LinkedIn, Twitter or Facebook.

About Kinaxis Inc.
Offering the industry's only concurrent planning solution, Kinaxis is helping organizations around the world revolutionize their supply chain planning. Kinaxis RapidResponse, our cloud-based supply chain management software, connects your data, processes and people into a single harmonious environment. With a consolidated view of the entire supply chain, you can plan expected performance, monitor progress and respond to disconnects when reality hits. RapidResponse lets you know sooner and act faster, leading to reduced decision latency, and improved operational and financial performance. We can prove it. From implementation to expansion, we help our customers with every step of their supply chain journey.

About Nucleus Research
Nucleus Research is a global provider of investigative, case-based technology research and advisory services, delivering the numbers that drive business decisions. For more information, visit NucleusResearch.com or follow on Twitter @NucleusResearch.

SOURCE Kinaxis Inc.


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: